Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barbolosi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Bio-Medical Computing|June 1, 1994
Dosage regimen calculations with optimal control theoryA Iliadis, D Barbolosi
Computers and Biomedical Research, an International Journal|June 22, 2000
Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical modelA Iliadis, D Barbolosi
Computers in Biology and Medicine|February 15, 2001
Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD modelD Barbolosi, A Iliadis
Current Topics in Medicinal Chemistry|September 18, 2012
A new model for determining the MTD during phase-I trials in pediatric oncologyC Faivre, D Barbolosi, A Iliadis
Cancer Chemotherapy and Pharmacology|February 8, 2013
A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimensC Faivre, D Barbolosi, E Pasquier, et al.
British Journal of Cancer|January 13, 2017
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patientsC Faivre, R El Cheikh, D Barbolosi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 25, 2008
An interface model for dosage adjustment connects hematotoxicity to pharmacokineticsC Meille, A Iliadis, D Barbolosi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chessJ Ciccolini, D Barbolosi, N André, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Information tools for exploratory data analysis in population pharmacokineticsO Petricoul, L Claret, D Barbolosi, et al.
Clinical Pharmacology and Therapeutics|October 25, 2007
New adaptive method for phase I trials in oncologyC Meille, J C Gentet, D Barbolosi, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Bio-Medical Computing|June 1, 1994
Dosage regimen calculations with optimal control theoryA Iliadis, D Barbolosi
Computers and Biomedical Research, an International Journal|June 22, 2000
Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical modelA Iliadis, D Barbolosi
Computers in Biology and Medicine|February 15, 2001
Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD modelD Barbolosi, A Iliadis
Current Topics in Medicinal Chemistry|September 18, 2012
A new model for determining the MTD during phase-I trials in pediatric oncologyC Faivre, D Barbolosi, A Iliadis
Cancer Chemotherapy and Pharmacology|February 8, 2013
A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimensC Faivre, D Barbolosi, E Pasquier, et al.
British Journal of Cancer|January 13, 2017
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patientsC Faivre, R El Cheikh, D Barbolosi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 25, 2008
An interface model for dosage adjustment connects hematotoxicity to pharmacokineticsC Meille, A Iliadis, D Barbolosi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chessJ Ciccolini, D Barbolosi, N André, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Information tools for exploratory data analysis in population pharmacokineticsO Petricoul, L Claret, D Barbolosi, et al.
Clinical Pharmacology and Therapeutics|October 25, 2007
New adaptive method for phase I trials in oncologyC Meille, J C Gentet, D Barbolosi, et al.
Pageof 2